FBLIM1P2

Across TCGA pan-cancer cohorts, FBLIM1P2 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of FBLIM1P2’s most consistent transcriptional readouts.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where FBLIM1P2 RNA is repressed in tumor relative to normal tissue. In most cancer types FBLIM1P2 is over-expressed in tumor, although a few such as PAAD show the opposite, repressed pattern.

PAAD, COAD, and LIHC are the cancer types where FBLIM1P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FBLIM1P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PAAD	Male	All	−0.110	.008	2	view →
COAD	All	All	+0.042	.028	2	view →
LIHC	All	All	+0.007	.023	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

FBLIM1P2–PAAD

Open the PAAD breakdown →